Utah Medical Products Inc (UTMD)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $204.92M
Last updated: Nov 17, 2026 at 11:05 AM ET
Dividends
Next ex-dividend: Dec 17, 2026
Dividend Metrics
Growth
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 0.9% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 49.6, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about UTMD
GNG News
All UTMD newsNews
UTMD Valuation
GNG's valuation label for UTMD is Fairly valued. It trades at 13.0x forward earnings and 21.7x trailing earnings.
- P/E
- 21.7x
- Forward P/E
- 13.0x
- EV/EBITDA
- 12.0x
- P/FCF
- 21.2x
- PEG
- 4.3
- P/B
- 1.9x
UTMD Profitability: Margins, ROIC and FCF
Utah Medical Products (UTMD) has a gross margin of 57.7%, an operating margin of 34.3% and a net margin of 30.5%. It posts 6.7% ROIC and a 31.1% FCF margin.
- Gross margin
- 57.7%
- Operating margin
- 34.3%
- Net margin
- 30.5%
- ROIC
- 6.7%
- ROE
- 8.8%
- FCF margin
- 31.1%
- FCF yield
- 4.7%
Utah Medical Products Competitors
The companies most similar to Utah Medical Products (UTMD) include KORU Medical Systems, Pro-Dex and OraSure Technologies.
Sector: Healthcare
Companies most similar to Utah Medical ProductsUTMD Bull Case vs Bear Case
Bull case
- UTMD converts 31.1% of revenue into free cash flow.
- UTMD has a 30.5% net profit margin.
- UTMD beat EPS estimates in 75.0% of its last 8 reported quarters.
Bear case
- UTMD's quarterly revenue changed -12.1% year over year.
UTMD Earnings: Beat Rate
Utah Medical Products (UTMD) beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate (75.0%). Its next report is expected on Jan 27, 2027.
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- 14.4%
UTMD Dividend
Utah Medical Products (UTMD) pays $1.24 a share a year, a 1.7% forward dividend yield.
- Forward yield
- 1.7%
- Payout ratio
- 34.4%
- 3Y DPS growth
- 1.7%
- 5Y DPS growth
- 1.7%
- Pay months
- Jan, Apr, Jul, Oct
UTMD Earnings Date
UTMD reports Jan 27, 2027. The date is estimated.
UTMD ETF Holders
GNG tracks 6 ETFs that hold UTMD. The largest weights:
- iShares Russell 2000 ETF (IWM), 0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Dimensional U.S. Core Equity 2 ETF (DFAC), <0.01% of the fund
- Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About UTMD
When is UTMD's next ex-dividend date?
UTMD's next ex-dividend date is Dec 17, 2026, for a declared dividend of $0.315 per share (record date Dec 17, 2026, payable Jan 5, 2027).
When does UTMD report earnings?
Utah Medical Products Inc (UTMD) is expected to report earnings on Jan 27, 2027.
What is UTMD's current dividend yield?
Utah Medical Products Inc (UTMD) has a forward dividend yield of 1.71%.
Does UTMD pay dividends?
Yes, Utah Medical Products Inc pays dividends with a forward dividend yield of 1.71%.
What is UTMD's P/E ratio?
Utah Medical Products Inc has a price-to-earnings (P/E) ratio of 21.68.
UTMD pages: Overview, Dividends, Earnings, Financials, Valuation, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.